Cancer Screening

Overview

Journal J Epidemiol Community Health

Specialty Health Services

Date 2002 Dec 4

PMID 12461108

Citations 9

Authors

A Barratt

P MANNES

L Irwig

L Trevena

J Craig

L Rychetnik

Affiliations

Soon will be listed here.

Abstract

"Screening is the systematic application of a test or inquiry, to identify individuals at sufficient risk of a specific disorder to benefit from further investigation or direct preventive action, among persons who have not sought medical attention on account of symptoms of that disorder."

Citing Articles

Uptake of Lung Cancer Screening CT After a Provider Order for Screening in the PROSPR-Lung Consortium.

Neslund-Dudas C, Tang A, Alleman E, Zarins K, Li P, Simoff M J Gen Intern Med. 2023; 39(2):186-194.

PMID: 37783984 PMC: 10853157. DOI: 10.1007/s11606-023-08408-9.

Joint Asian Pacific Association of Gastroenterology (APAGE)-Asian Pacific Society of Digestive Endoscopy (APSDE) clinical practice guidelines on the use of non-invasive biomarkers for diagnosis of colorectal neoplasia.

Chan F, Wong M, Chan A, East J, Chiu H, Makharia G Gut. 2023; 72(7):1240-1254.

PMID: 37019620 PMC: 10314015. DOI: 10.1136/gutjnl-2023-329429.

Efficacy of an optimal ovarian cancer screening: a best-case scenario study based on real-world data.

Steinkasserer L, Irmgard D, Weiss T, Dirschlmayer W, Mossig M, Zeimet A Arch Gynecol Obstet. 2021; 305(1):159-167.

PMID: 34125280 PMC: 8782802. DOI: 10.1007/s00404-021-06117-4.

Prostate Cancer Screening with PSA: Ten Years' Experience of Population Based Early Prostate Cancer Detection Programme in Lithuania.

Patasius A, Krilaviciute A, Smailyte G J Clin Med. 2020; 9(12).

PMID: 33255919 PMC: 7760278. DOI: 10.3390/jcm9123826.

Systematic screening for the detection of atrial fibrillation.

Moran P, Teljeur C, Ryan M, Smith S Cochrane Database Syst Rev. 2016; (6):CD009586.

PMID: 27258214 PMC: 7105908. DOI: 10.1002/14651858.CD009586.pub3.

References

Petticrew M, Sowden A, Wright K . False-negative results in screening programmes: systematic review of impact and implications. Health Technol Assess. 2000; 4(5):1-120. View

Barratt A, Irwig L, Glasziou P, Cumming R, Raffle A, Hicks N . Users' guides to the medical literature: XVII. How to use guidelines and recommendations about screening. Evidence-Based Medicine Working Group. JAMA. 1999; 281(21):2029-34. DOI: 10.1001/jama.281.21.2029. View

Raffle A . Information about screening - is it to achieve high uptake or to ensure informed choice?. Health Expect. 2001; 4(2):92-8. PMC: 5060056. DOI: 10.1046/j.1369-6513.2001.00138.x. View

Wald N . Guidance on terminology. J Med Screen. 2001; 8(1):56. DOI: 10.1136/jms.8.1.56. View

Law M . The number needed to screen--an adaptation of the number needed to treat. J Med Screen. 2001; 8(3):114-5. DOI: 10.1136/jms.8.3.114. View

Richardson A . Screening and the number needed to treat. J Med Screen. 2001; 8(3):125-7. DOI: 10.1136/jms.8.3.125. View

Olsen O, Gotzsche P . Cochrane review on screening for breast cancer with mammography. Lancet. 2001; 358(9290):1340-2. DOI: 10.1016/S0140-6736(01)06449-2. View

Schoen R, Weissfeld J, Trauth J, Ling B, Hayran M . A population-based, community estimate of total colon examination: the impact on compliance with screening for colorectal cancer. Am J Gastroenterol. 2002; 97(2):446-51. DOI: 10.1111/j.1572-0241.2002.05484.x. View

Walter S, Day N . Estimation of the duration of a pre-clinical disease state using screening data. Am J Epidemiol. 1983; 118(6):865-86. DOI: 10.1093/oxfordjournals.aje.a113705. View

10.

Andersson I, Aspegren K, Janzon L, LANDBERG T, Lindholm K, Linell F . Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. BMJ. 1988; 297(6654):943-8. PMC: 1834636. DOI: 10.1136/bmj.297.6654.943. View

11.

Baines C, To T, Wall C . Women's attitudes to screening after participation in the National Breast Screening Study. A questionnaire survey. Cancer. 1990; 65(7):1663-9. DOI: 10.1002/1097-0142(19900401)65:7<1663::aid-cncr2820650735>3.0.co;2-a. View

12.

Eddy D . Comparing benefits and harms: the balance sheet. JAMA. 1990; 263(18):2493, 2498, 2501 passim. DOI: 10.1001/jama.263.18.2493. View

13.

Glasziou P . Meta-analysis adjusting for compliance: the example of screening for breast cancer. J Clin Epidemiol. 1992; 45(11):1251-6. DOI: 10.1016/0895-4356(92)90166-k. View

14.

Torgerson D, Donaldson C . An economic view of high compliance as a screening objective. BMJ. 1994; 308(6921):117-9. PMC: 2539240. DOI: 10.1136/bmj.308.6921.117. View

15.

Schulz K, Chalmers I, Hayes R, Altman D . Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995; 273(5):408-12. DOI: 10.1001/jama.273.5.408. View

16.

Raffle A . New tests in cervical screening. Lancet. 1998; 351(9098):297. DOI: 10.1016/S0140-6736(05)78229-5. View

17.

Fletcher S . Evidence-based screening: what kind of evidence is needed?. ACP J Club. 1998; 128(3):A12-4. View

18.

Quinn M, Babb P, Jones J, Allen E . Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. BMJ. 1999; 318(7188):904-8. PMC: 27810. DOI: 10.1136/bmj.318.7188.904. View

19.

Nottingham J . Women must be given fully informed information about cervical screening. BMJ. 1999; 318(7197):1555-6. PMC: 1115917. DOI: 10.1136/bmj.318.7197.1555a. View

20.

Goyder E, Barratt A, Irwig L . Telling people about screening programmes and screening test results: how can we do it better?. J Med Screen. 2000; 7(3):123-6. DOI: 10.1136/jms.7.3.123. View